Your session is about to expire
← Back to Search
Afferent Block for Heart Failure
Study Summary
This trial will help researchers understand why patients with heart failure and preserved ejection fraction (HFpEF) are intolerant to exercise, and if regular physical activity can help improve this.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My heart pumps less blood than normal.My heart pumps well but is stiff.
- Group 1: Afferent effect on hemodynamics
- Group 2: Afferent effect on fatigue
- Group 3: Effect of cardiac rehab
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are eligible to join this experiment?
"Affirmative. The information available at clinicaltrials.gov indicates that this trial, initially posted on May 2nd 2022, is actively recruiting 50 participants from a single location."
What is the ideal demographic for this experiment?
"This clinical trial seeks 50 participants with heart failure and preserved ejection fraction (hfpef) between 21 and 85 years of age."
Does this research endeavor accept individuals aged 55 and older to participate?
"This medical research is open to individuals aged 21 and above, but below 85."
Are researchers currently looking for participants in this trial?
"This medical investigation is currently recruiting, with an initial posting of May 2nd 2022 and subsequent amendment on the 17th. The information can be accessed via clinicaltrials.gov."
Share this study with friends
Copy Link
Messenger